Related references
Note: Only part of the references are listed.TAK1 inhibitor 5Z-7-oxozeaenol sensitizes neuroblastoma to chemotherapy
Yihui Fan et al.
APOPTOSIS (2013)
Conformational stabilization of ubiquitin yields potent and selective inhibitors of USP7
Yingnan Zhang et al.
NATURE CHEMICAL BIOLOGY (2013)
The genetic landscape of high-risk neuroblastoma
Trevor J. Pugh et al.
NATURE GENETICS (2013)
MDM2, MDMX and p53 in oncogenesis and cancer therapy
Mark Wade et al.
NATURE REVIEWS CANCER (2013)
The p53 pathway in hematopoiesis: lessons from mouse models, implications for humans
Vinod Pant et al.
BLOOD (2012)
A Small Molecule Inhibitor of Ubiquitin-Specific Protease-7 Induces Apoptosis in Multiple Myeloma Cells and Overcomes Bortezomib Resistance
Dharminder Chauhan et al.
CANCER CELL (2012)
Discovery of Specific Inhibitors of Human USP7/HAUSP Deubiquitinating Enzyme
Celine Reverdy et al.
CHEMISTRY & BIOLOGY (2012)
Effect of MDM2 and vascular endothelial growth factor inhibition on tumor angiogenesis and metastasis in neuroblastoma
Danielle M. Patterson et al.
ANGIOGENESIS (2011)
Activity-Based Chemical Proteomics Accelerates Inhibitor Development for Deubiquitylating Enzymes
Mikael Altun et al.
CHEMISTRY & BIOLOGY (2011)
Nutlin-3a Is a Potential Therapeutic for Ewing Sarcoma
Kathleen I. Pishas et al.
CLINICAL CANCER RESEARCH (2011)
The p53 Pathway as a Target in Cancer Therapeutics: Obstacles and Promise
Anna Mandinova et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Immunology and immunotherapy of neuroblastoma
Robert C. Seeger
SEMINARS IN CANCER BIOLOGY (2011)
Genetically engineered murine models - Contribution to our understanding of the genetics, molecular pathology and therapeutic targeting of neuroblastoma
Louis Chesler et al.
SEMINARS IN CANCER BIOLOGY (2011)
Reactivation of p53: from peptides to small molecules
Christopher J. Brown et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2011)
The Mdm2-p53 relationship evolves: Mdm2 swings both ways as an oncogene and a tumor suppressor
James J. Manfredi
GENES & DEVELOPMENT (2010)
Medical Progress: Recent Advances in Neuroblastoma.
John M. Maris
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Inactivation of HAUSP in vivo modulates p53 function
N. Kon et al.
ONCOGENE (2010)
p53 post-translational modification: deregulated in tumorigenesis
Chao Dai et al.
TRENDS IN MOLECULAR MEDICINE (2010)
Modes of p53 Regulation
Jan-Philipp Kruse et al.
CELL (2009)
Small-molecule inhibitor of USP7/HAUSP ubiquitin protease stabilizes and activates p53 in cells
Frederic Colland et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Tumor Suppressive Functions of p53
Jack T. Zilfou et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2009)
Targeting ubiquitin specific proteases for drug discovery
Laurent Daviet et al.
BIOCHIMIE (2008)
Hyperubiquitylation of wild-type p53 contributes to cytoplasmic sequestration in neuroblastoma
K. Becker et al.
CELL DEATH AND DIFFERENTIATION (2007)
Functional characterization of a new p53 mutant generated by homozygous deletion in a neuroblastoma cell line
Yohko Nakamura et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
MDM2 inhibition sensitizes neuroblastoma to chemotherapy-induced apoptotic cell death
Eveline Barbieri et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Promoting apoptosis as a strategy for cancer drug discovery
SW Fesik
NATURE REVIEWS CANCER (2005)
Small molecule inhibitors of HDM2 ubiquitin ligase activity stabilize and activate p53 in cells
YL Yang et al.
CANCER CELL (2005)
Long-term complications in survivors of advanced stage neuroblastoma
C Laverdiere et al.
PEDIATRIC BLOOD & CANCER (2005)
A dynamic role of HAUSP in the p53-Mdm2 pathway
MY Li et al.
MOLECULAR CELL (2004)
The requirement for evasion of programmed cell death in neuroblastomas with MYCN amplification
MD Hogarty
CANCER LETTERS (2003)
SUMO-1 modification of Mdm2 prevents its self-ubiquitination and increases Mdm2 ability to ubiquitinate p53
T Buschmann et al.
CELL (2000)
The loss of mdm2 induces p53 mediated apoptosis
S de Rozieres et al.
ONCOGENE (2000)
Share Paper
